NEA Management Company’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

NEA Management Company’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,362,986	Closed	-$35.3M	–	64
2021 Q3	$35.3M	Hold	4,362,986	–	–	0.42%	23
2021 Q2	$42.9M	Hold	4,362,986	–	–	0.56%	26
2021 Q1	$38.5M	Hold	4,362,986	–	–	0.86%	27
2020 Q4	$44.6M	Hold	4,362,986	–	–	1.18%	22
2020 Q3	$39.4M	Hold	4,362,986	–	–	1.67%	19
2020 Q2	$31.2M	Hold	4,362,986	–	–	1.25%	20
2020 Q1	$41.4M	Hold	4,362,986	–	–	2.17%	16
2019 Q4	$57.4M	Buy	+4,362,986	New	+$53.2M	2.72%	13

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NEA Management Company's GRTX Position: Q4 2021 in Review

NEA Management Company sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 4,362,986 shares — an estimated $35.3M sold.

NEA Management Company first reported a position in GRTX in Q4 2019 and held it in 8 quarters. The position peaked at $57.4M in Q4 2019. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

NEA Management Company reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
NEA Management Company sold 4,362,986 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $35.3M.
NEA Management Company first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
NEA Management Company's Galera Therapeutics, Inc. Common Stock position peaked at $57.4M in Q4 2019.
44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on NEA Management Company's 13F filing for Q4 2021, filed 14 Feb 2022.